|
Delayed
London S.E.
11:57:46 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.3000 GBX | 0.00% |
|
-4.76% | -72.09% |
| 10-26 | Angus Energy output falls; One Health revenue up | AN |
| 10-26 | Aptamer, Pharmahungary to Research Therapeutics Delivery to Heart, Skeletal Muscle | MT |
Company Valuation: Aptamer Group PLC
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 66.26 | 4.664 | 3.038 | 8.165 |
| Change | - | -92.96% | -34.86% | 168.77% |
| Enterprise Value (EV) 1 | 60.88 | 5.508 | 2.985 | 7.597 |
| Change | - | -90.95% | -45.81% | 154.51% |
| P/E | -29.6x | -0.59x | -0.91x | -2.93x |
| PBR | 8.23x | 15.3x | 3.43x | 5.91x |
| PEG | 0.3x | -0x | 0x | 0x |
| Capitalization / Revenue | 16.4x | 2.66x | 3.53x | 6.79x |
| EV / Revenue | 15.1x | 3.14x | 3.47x | 6.31x |
| EV / EBITDA | -25.2x | -1.07x | -1.02x | -3.17x |
| EV / EBIT | -24.2x | -0.99x | -0.97x | -2.99x |
| EV / FCF | -29.7x | -1.21x | -1.99x | -5.9x |
| FCF Yield | -3.37% | -82.9% | -50.4% | -16.9% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.0324 | -0.1135 | -0.007125 | -0.0014 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 4.036 | 1.752 | 0.86 | 1.203 |
| EBITDA 1 | -2.42 | -5.155 | -2.933 | -2.395 |
| EBIT 1 | -2.517 | -5.556 | -3.084 | -2.539 |
| Net income 1 | -2.093 | -7.836 | -2.958 | -2.424 |
| Net Debt 1 | -5.383 | 0.844 | -0.053 | -0.568 |
| Reference price 2 | 0.960000 | 0.067500 | 0.006500 | 0.004100 |
| Nbr of stocks (in thousands) | 69,023 | 69,092 | 467,344 | 1,991,343 |
| Announcement Date | 10/17/22 A | 11/21/23 A | 11/5/24 A | 12/16/25 A |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 13.8M | |
| 36.06x | 6.09x | 23.28x | 0.26% | 260B | |
| 37.21x | 7.05x | 22.09x | 0.62% | 165B | |
| 51.2x | 12.41x | 26.62x | -.--% | 154B | |
| 16.67x | 3.37x | 10.92x | -.--% | 61.49B | |
| 36.38x | 7.29x | 23.05x | -.--% | 52.9B | |
| 20.86x | 2.49x | 12.59x | 2.42% | 52.84B | |
| 48.66x | 12.03x | 26.52x | -.--% | 51.46B | |
| 35.36x | 7x | 23.77x | 0.57% | 51.16B | |
| 83.48x | 7.91x | 24.03x | -.--% | 46.85B | |
| Average | 40.65x | 7.29x | 21.43x | 0.43% | 89.57B | |
| Weighted average by Cap. | 39.83x | 7.51x | 22.39x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- APTA Stock
- Valuation Aptamer Group PLC
Select your edition
All financial news and data tailored to specific country editions
